| Treatment Strategy for Patients With RA-ILD (NCT07643038) | Chinese SLE Treatment And Research Group | 2026-07-01 |
| Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus (NCT07381465) | Chinese SLE Treatment And Research Group | 2026-06-16 |
| Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia (NCT07657793) | Chinese SLE Treatment And Research Group | 2026-06-07 |
| The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis (NCT07013838) | Chinese SLE Treatment And Research Group | 2025-06-15 |
| Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus (NCT06881290) | Chinese SLE Treatment And Research Group | 2025-05-19 |
| Chinese Rheumatism Biobank(CRB) (NCT06887517) | Chinese SLE Treatment And Research Group | 2025-02-10 |
| A Study on the Prevention and Treatment of GIOP With Eldecalcitol (NCT06385093) | Chinese SLE Treatment And Research Group | 2024-06-01 |
| Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis (NCT06167174) | Chinese SLE Treatment And Research Group | 2023-12-05 |
| Bortezomib for the Treatment of Refractory Rheumatoid Arthritis (NCT05805891) | Chinese SLE Treatment And Research Group | 2023-12-01 |
| Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus (NCT05916781) | Chinese SLE Treatment And Research Group | 2023-07-01 |
| Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM) (NCT05962840) | Chinese SLE Treatment And Research Group | 2023-06-29 |
| Anti-CD20 Antibodies for Treatment of SLE-PAH (NCT05828147) | Chinese SLE Treatment And Research Group | 2023-05-25 |
| Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM) (NCT05965284) | Chinese SLE Treatment And Research Group | 2023-03-09 |
| Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis (NCT05749666) | Chinese SLE Treatment And Research Group | 2023-01-20 |
| Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis (NCT05151848) | Chinese SLE Treatment And Research Group | 2022-01-05 |
| Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis (NCT04737343) | Chinese SLE Treatment And Research Group | 2021-06-30 |
| Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus (NCT04582136) | Chinese SLE Treatment And Research Group | 2021-03-04 |
| The Survey of Satisfaction in Chinese Rheumatologists and Patients With Rheumatoid Arthritis (NCT03483597) | Chinese SLE Treatment And Research Group | 2018-03-31 |